Company intelligence / Profile preview

GeneWorld

Daejeon, Daejeon, South Korea

Ownership: Private
Development stage: Other

Overview

GeneWorld is a South Korean biotechnology company specializing in the development and manufacture of molecular diagnostic systems and reagents. Founded in 2000, the company focuses on providing high-sensitivity PCR-based kits for the detection of infectious diseases, including tuberculosis, COVID-19, and various sexually transmitted infections. Their product portfolio includes automated DNA/RNA extraction systems and real-time PCR diagnostic kits that are utilized in clinical laboratories and hospitals. GeneWorld aims to improve global health outcomes through the early and accurate detection of pathogens using advanced genomic technologies.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Molecular diagnosticsPCR-based diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on GeneWorld.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneWorld.

Explore the full profile